Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 36Kidney Neoplasms 9Neoplasm Metastasis 7Neoplasms 6Melanoma 5Colorectal Neoplasms 5Glioblastoma 4Carcinoma, Hepatocellular 4Recurrence 3Clear-cell metastatic renal cell carcinoma 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Liver Neoplasms 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Adenoid Cystic 2cT2a N0NxM0 Renal Tumor 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Solitary Fibrous Tumors 1Solid Malignancies 1Skin Neoplasms 1Sarcoma, Alveolar Soft Part 1Salivary Gland Neoplasms 1Relapsed Pediatric Solid Tumor 1Radiation Therapy 1Prostatic Neoplasms 1Pheochromocytoma 1Paraganglioma 1Ovarian Neoplasms 1

Interventions

Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Solid Malignancies × Axitinib × Clear all
NCT01540526 2019-11-19

Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib

University of Wisconsin, Madison

Phase 1 Completed
24 enrolled
Genitourinary

Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡